Immune Technologies & Medicine GmbH
1 clinical trials · Sponsor
◉ Watch Immune Technologies & Medicine GmbH
| Record | Firm | Date |
|---|---|---|
| Combined Inhibition of Dipeptidyl Peptidase IV (DPIV/CD26) and Aminopeptidase N (APN/CD13) in the Treatment of Psoriasis (NCT00824980) | Immune Technologies & Medicine GmbH | 2009-01-01 |
Track Immune Technologies & Medicine GmbH automatically
Every clearance here is in the API, with alerts when new ones post.